© 2026 WCBE 90.5 FM

WCBE is a broadcast service of Columbus City Schools.
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
OUR OFFICES WILL BE CLOSED FRIDAY, APRIL 3RD THROUGH TUESDAY, APRIL 6TH FOR CCS SPRING BREAK. WE WILL REOPEN WEDNESDAY, APRIL 7TH.

FDA Approves Pill With Sensor To Send Information To Doctor

NPR
Published November 15, 2017 at 12:33 PM EST
This photo provided by Otsuka America Pharmaceutical, Inc. shows a rendering of the packaging for Abilify MyCite. On Monday, Nov. 13, 2017, the FDA approved Abilify MyCite, the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. (Otsuka America Pharmaceutical, Inc. via AP)
This photo provided by Otsuka America Pharmaceutical, Inc. shows a rendering of the packaging for Abilify MyCite. On Monday, Nov. 13, 2017, the FDA approved Abilify MyCite, the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. (Otsuka America Pharmaceutical, Inc. via AP)

A new antipsychotic pill contains an ingestible sensor which can transmit information to the patient’s doctor. The pill is designed to help patients take medication consistently, but it also raises some privacy concerns.

Rebecca Robbins (@rebeccadrobbins) of our partner STAT discusses with Here & Now‘s Jeremy Hobson.

Copyright 2021 NPR. To see more, visit https://www.npr.org.